Literature DB >> 10397721

The receptor protein tyrosine phosphatase, PTP-RO, is upregulated during megakaryocyte differentiation and Is associated with the c-Kit receptor.

Y Taniguchi1, R London, K Schinkmann, S Jiang, H Avraham.   

Abstract

We have recently isolated a cDNA encoding a novel human receptor-type tyrosine phosphatase, termed PTP-RO (for a protein tyrosine phosphatase receptor omicron), from 5-fluorouracil-treated murine bone marrow cells. PTP-RO is a human homologue of murine PTPlambda and is related to the homotypically adhering kappa and mu receptor-type tyrosine phosphatases. PTP-RO is expressed in human megakaryocytic cell lines, primary bone marrow megakaryocytes, and stem cells. PTP-RO mRNA and protein expression are upregulated upon phorbol 12-myristate 13-acetate (PMA) treatment of the megakaryocytic cell lines CMS, CMK, and Dami. To elucidate the function of PTP-RO in megakaryocytic cells and its potential involvement in the stem cell factor (SCF)/c-Kit receptor pathway, COS-7 and 293 cells were cotransfected with the cDNAs of both the c-Kit tyrosine kinase receptor and PTP-RO. PTP-RO was found to be associated with the c-Kit receptor in these transfected cells and the SCF/Kit ligand induced a rapid tyrosine phosphorylation of PTP-RO. Interestingly, these transfected cells demonstrated a decrease in their proliferative response to the SCF/Kit ligand. In addition, we assessed the association of PTP-RO with c-Kit in vivo. The results demonstrated that PTP-RO associates with c-Kit but not with the tyrosine kinase receptor FGF-R and that PTP-RO is tyrosine-phosphorylated after SCF stimulation of Mo7e and CMK cells. Antisense oligonucleotides directed against PTP-RO mRNA sequences significantly inhibited megakaryocyte progenitor proliferation. Therefore, these data show that the novel tyrosine kinase phosphatase PTP-RO is involved in megakaryocytopoiesis and that its function is mediated by the SCF/c-Kit pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397721

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

2.  Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma.

Authors:  Thomas K Ni; Sean F Landrette; Robert D Bjornson; Marcus W Bosenberg; Tian Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

Review 3.  Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Semin Cell Dev Biol       Date:  2014-09-16       Impact factor: 7.727

4.  Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.

Authors:  Min Yu; Guang Lin; Niloofar Arshadi; Irina Kalatskaya; Bin Xue; Syed Haider; Francis Nguyen; Paul C Boutros; Ari Elson; Lakshmi B Muthuswamy; Nicholas K Tonks; Senthil K Muthuswamy
Journal:  Mol Cell Biol       Date:  2012-07-30       Impact factor: 4.272

5.  Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).

Authors:  Maria Chiara Pelleri; Allison Piovesan; Maria Caracausi; Anna Concetta Berardi; Lorenza Vitale; Pierluigi Strippoli
Journal:  BMC Med Genomics       Date:  2014-12-05       Impact factor: 3.063

6.  A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.

Authors:  Olivia Bibollet-Bahena; Tatsuya Okafuji; Karsten Hokamp; Guy Tear; Kevin J Mitchell
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

7.  PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway.

Authors:  Jiayi Gu; Zhiqi Zhang; Tingyuan Lang; Xinlin Ma; Linxi Yang; Jia Xu; Cong Tian; Kun Han; Jiangfeng Qiu
Journal:  Onco Targets Ther       Date:  2019-10-04       Impact factor: 4.147

8.  Sex-Specific Transcriptome Differences in Human Adipose Mesenchymal Stem Cells.

Authors:  Eva Bianconi; Raffaella Casadei; Flavia Frabetti; Carlo Ventura; Federica Facchin; Silvia Canaider
Journal:  Genes (Basel)       Date:  2020-08-08       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.